Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Raptor Pharmaceutical Corp.
Lobbying Relationship
Bills mentioned
H.R.5122: To prohibit further action on the proposed rule regarding testing of...
Sponsor: Larry Bucshon (R-Ind.)
H.R.3513: Prescription Drug Affordability Act of 2015
Sponsor: Elijah E. Cummings (D-Md.)
H.R.9: Innovation Act
Sponsor: Robert W. Goodlatte (R-Va.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Darren Willcox | Asst for Policy, Speaker Dennis Hastert; Admin Asst, Leg Dir, Leg Asst, Cong. Porter Goss; House Rules Comm Assoc, Subcomm Staff Dir. |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate